Elliott Robinson - 18 Nov 2025 Form 4 Insider Report for Hinge Health, Inc. (HNGE)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: HNGE
Reported as of: 18 Nov 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Nov 2025, 18:54:15 UTC
Prior SEC filing: 21 May 2025
Next SEC filing: 01 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Augie Wilkinson, Attorney-in-Fact

Key filing fact

Elliott Robinson filed Form 4 for Hinge Health, Inc. (HNGE) on 20 Nov 2025.

Key facts

This page summarizes Elliott Robinson's Form 4 filing for Hinge Health, Inc. (HNGE).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 20 Nov 2025, 18:54.

Change

Previous filing in this sequence was filed on 21 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002058536 Primary reporting owner

Robinson Elliott

Relationship: Director, 10%+ Owner
Address: C/O BESSEMER VENTURE PARTNERS, 1865 PALMER AVENUE, SUITE 104, LARCHMONT
Signature: /s/ Augie Wilkinson, Attorney-in-Fact
Signature date: 20 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HNGE transaction

Class A Common Stock

Conversion of derivative security

Transaction value
Shares: 0
Change %
Price
Shares after: 0
Date: 18 Nov 2025
Ownership: See footnote
Footnotes: F1, F3

HNGE transaction

Class A Common Stock

Sale

Transaction value: $0
Shares: 0
Change %
Price: $0.000000^*
Shares after: 0
Date: 18 Nov 2025
Ownership: See footnote
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HNGE transaction Derivative

Class B Common Stock

Conversion of derivative security

Transaction value
Shares: 0
Change %
Price
Shares after: 0
Date: 18 Nov 2025
Ownership: See footnote
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On November 18, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") converted 2,119,271 and 1,989,436 shares of Class B Common Stock of the Issuer, respectively, into 2,119,271 and 1,989,436 shares of Class A Common Stock of the issuer, respectively. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation.

Footnote F2

BVP X sold 373,955 shares of Class A Common Stock of the Issuer, and BVP X Inst. sold 351,045 shares of Class A Common Stock of the Issuer.

Footnote F3

The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.